You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
13 July 2026 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Monday that it has received marketing authorisation in Sweden for Tofacitinib Newbury 5 mg and 10 mg film-coated tablets, marking the first approval in...
13 July 2026 - Evaxion A/S (NASDAQ: EVAX), a Denmark-based clinical-stage TechBio company developing novel vaccines with its AI-Immunology platform, on Sunday presented new data further supporting the multi-component concept of its cytomegalovirus (C...
13 July 2026 - US-based clinical-stage biotechnology company HDT Bio Corp announced on Sunday the establishment of HDT Bio Canada Inc, its Canadian subsidiary, formed to advance its cancer immunotherapy programs through Canadian clinical development,...
13 July 2026 - Clinical-stage biotechnology company Insilico Medicine (HKEX:3696) announced on Sunday that it has agreed an additional AI-empowered drug discovery collaboration with China Medical System Holdings Limited (CMS) (HKEX:867) (SGX:8A8) tar...
13 July 2026 - Chinese biotech company Antengene Corporation Limited (SEHK:6996) announced on Monday that the company has received a USD60m upfront payment from UCB (Euronext Brussels:UCB) under the worldwide exclusive licence agreement for ATG-201, ...
10 July 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Friday that the US Food and Drug Administration (FDA) has approved the company's subcutaneous Sarclisa (isatuximab-irfc) Escena for use in combin...
10 July 2026 - Accord BioPharma, the US specialty division of India-based Intas Pharmaceuticals Ltd, focused on the development of oncology, immunology, and central nervous system (CNS) therapies, announced on Thursday that the US Food and Drug Admin...